Skip to main content
    B

    Bruker Corporation (BRKR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $60.62
    -0.97 (-1.57%)

    Market Cap: $9.41B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bruker Corporation (BRKR) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Bruker (BRKR) trades at 31.1x trailing earnings and 2.6x sales. Its P/E of 31.1x is above its 5-year median of 27.3x. Its forward P/E is 13.8x. The median P/E across 9 similar companies is 23.8x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 125.4% higher over the next year. Its free cash flow yield is 2.6%.

    MultipleValue
    P/E (trailing)31.1x
    Forward P/E13.8x
    Price to sales2.6x
    EV/EBITDA68.8x
    Price to FCF37.8x
    EV/FCF44.3x
    PEG1.5
    FCF yield2.6%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 12.7% above 27.6x and its P/S is 7.1% below 2.8x.

    MultipleCurrent5-year median10-year median
    P/E31.1x27.3x27.6x
    P/S2.6x3.2x2.8x
    P/BN/AN/A7.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 106 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 17.8x in 2016 to 40.1x in 2020.

    Year endPriceP/EP/SP/B
    2025$47.1125.7x2.1x2.9x
    2024$58.6224.3x2.6x5.0x
    2023$73.4828.5x3.6x7.8x
    2022$68.3529.2x4.0x9.1x
    2021$83.9140.0x5.3x12.0x
    2020$54.1340.1x4.2x8.7x
    2019$50.9732.5x1.9x8.7x
    2018$29.7721.3x2.5x5.2x
    2017$34.3228.1x3.1x7.3x
    2016$21.1817.8x2.1x4.9x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About BRKR

    What is BRKR's forward P/E ratio?

    Bruker has a forward P/E ratio of 13.8x.

    Is BRKR stock overvalued?

    GNG's valuation label for BRKR is Undervalued. Its P/E of 31.1x compares with a median of 23.8x across 9 similar companies.

    What is BRKR's price to sales ratio?

    Bruker has a price to sales ratio of 2.6x.

    What is Bruker's average P/E ratio over 5 years?

    Bruker's median P/E over the last 5 years is 27.3x, from 60 month-end values through Oct 2026.

    What is BRKR's PEG ratio?

    Bruker has a PEG ratio of 1.5.